HLN - Haleon plc - Stock Price & Dividends

Haleon plc is a leading consumer healthcare company that develops, manufactures, and sells a wide range of products to promote health and wellbeing. With a presence in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific, the company's products are designed to address various health needs, from oral health to pain relief and digestive health.

The company's oral health portfolio includes popular brands such as Sensodyne, Polident, and Parodontax, offering toothpastes, mouthwashes, and denture care products. Additionally, Haleon provides vitamins, minerals, and supplements under well-known brands like Centrum, Emergen-C, and Caltrate, supporting overall health and nutrition.

Haleon's over-the-counter (OTC) product range is extensive, featuring brands like Otrivine, Theraflu, and Flonase for respiratory issues, as well as Voltaren, Panadol, and Advil for pain relief and anti-inflammatory needs. The company also offers antacids and antihistamine products under TUMS, ENO, and Fenistil brands, catering to digestive health and other issues.

With a rich history dating back to 1715, Haleon plc was previously known as DRVW 2022 plc before adopting its current name in February 2022. The company is headquartered in Weybridge, the United Kingdom, and operates a global website at https://www.haleon.com, providing access to its products and services worldwide.